Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Allyl bromide | HCID 7841 | — |
| Reactant | Diisopropylamine | HCID 7912 | — |
| Reactant | Lithium Chloride | HCID 433294 | — |
| Reactant | 1H-1-Benzazepine-2,5-dione, 3-methoxy- | HCID 10750663 | — |
| Reactant | Butyllithium | HCID 178418339 | — |
| Reactant | HCID 178506766 | HCID 178506766 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 18980008 | HCID 18980008 | 34% |
Reaction Steps
A solution of 3-methoxy-2,5-dioxo-2,5-dihydro-1H-benz[b]-azepine (10 g), lithium chloride (12.5 g) and diisopropylamine (7.5 mL) in tetrahydrofuran (200 mL) was cooled to -70° C.; and butyllithium (2.5M in hexanes, 43 mL) was added, maintaining the temperature below -60° C. The mixture was warmed to 20° C. for 1 hour, and cooled to -70° C. A portion of the resulting 2,5-dihydro-2,5-dioxo-1,4-dilithio-3-methoxy-1H-benz[b]azepine solution (0.188M in tetrahydrofuran, 26 mL) was added to a solution of allyl bromide (0.85 mL) in tetrahydrofuran (15 mL) at -70° C. The mixture was warmed to room temperature, diluted with water, acidified (2N hydrochloric acid) and extracted with ethyl acetate. The combined organic extracts were washed with brine, dried and evaporated. The solid was purified by chromatography, with ethyl acetate:toluene (1:3) as the eluent, to give the title compound (0.189 g, 34%); NMR: 5.77 (m,1); 4.99 (d,1) 4.94 (s,1) 3.29 (d,2); MS: m/z=244(M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05656626 |
|---|
| Source dataset | uspto-grants-1997_08 |
|---|
| ORD ID | ord-25480fb06b114284a172e0ea8e08184f |
|---|
| Source note | uspto-grants-1997_08 |
|---|